Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ulrike Mayr-Sponer"'
Autor:
Gabor Deak, Ursula Schmidt-Erfurth, Christian Simader, Matthias Bolz, Michael Kundi, Markus Ritter, Ramzi Sayegh, Ulrike Mayr-Sponer
Publikováno v:
British Journal of Ophthalmology. 98:1629-1635
Background/aims To investigate the impact of antiangiogenic monotherapy and photodynamic therapy (PDT) as add-on strategy on retinal morphology, and to analyse prognostic biomarkers for visual outcome and retreatment frequency in neovascular age-rela
Autor:
I. Golbaz, Ursula Schmidt-Erfurth, Markus Ritter, Matthias Bolz, Ulrike Mayr-Sponer, Michael Kundi, Gabor Deak, Christian Simader
Publikováno v:
Ophthalmology. 121:1237-1245
To identify the effects of anti-angiogenic therapy in neovascular age-related macular degeneration (AMD) in respect to morphologic type and time course and to identify prognostic factors for visual outcome on the basis of standardized optical coheren
Autor:
Ulrike Mayr-Sponer, Christian Simader, Ursula Schmidt-Erfurth, Andrea Papp, Markus Ritter, I. Golbaz, Michael Kundi, Sebastian M. Waldstein, Ursula Heiling
Publikováno v:
Ophthalmology. 120:2620-2629
Purpose To investigate the influence of the vitreomacular interface (VMI) on the functional and anatomic efficacy of ranibizumab therapy in patients with neovascular age-related macular degeneration (AMD). Design Subanalysis of a prospective, 12-mont
Autor:
Ulrike Mayr-Sponer, Ursula Schmidt-Erfurth, Christian Simader, Sebastian M. Waldstein, Markus Ritter, Michael Kundi
Publikováno v:
American journal of ophthalmology. 158(2)
Purpose To investigate the influence of vitreomacular adhesion on the efficacy of pro re nata (PRN) ranibizumab monotherapy and verteporfin photodynamic therapy (PDT) combination therapy for neovascular age-related macular degeneration. Design Post h